Loading the player...


INFO:
ASCO 2018 atezolizumab long-term efficacy data, recent safety alerts by the FDA highlighting the Keynote 361 and IMvigor 130 studies, IOs for bladder cancer, urothelial carcinoma, Arjun Balar and Alicia Morgans
Update in Immuno-Oncology in Bladder Cancer - Arjun Balar